CRF-41 stimulates the release of beta-lipotrophin and beta-endorphin in normal human subjects.
A prompt rise in circulating immunoreactive N- and C-terminal lipotrophin (LPH) accompanied the increase in ACTH when 100 micrograms CRF-41 was given to 6 normal male subjects. Chromatography of the basal and peak 15-min values showed that there was an equimolar increase in beta-LPH and beta-endorph...
Main Authors: | McLoughlin, L, Tomlin, S, Grossman, A, Lytras, N, Schally, A, Coy, D, Besser, G, Rees, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
1984
|
Similar Items
-
The pituitary-adrenal response to CRF-41 is unaltered by intravenous somatostatin in normal subjects.
by: Stafford, P, et al.
Published: (1989) -
Hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity: a study of ACTH, AVP, beta-lipotrophin and cortisol responses to insulin-induced hypoglycaemia.
by: Weaver, J, et al.
Published: (1993) -
Neuropeptide-Y stimulates CRF-41 release from rat hypothalami in vitro.
by: Tsagarakis, S, et al.
Published: (1989) -
Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
by: Lytras, N, et al.
Published: (1984) -
Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro.
by: Tsagarakis, S, et al.
Published: (1990)